Matthew Porteus

Matthew Porteus

Corporate Officer/Principal at
Stanford School of Medicine
61 year
Consumer Services
Health Technology

Profile

Matthew Porteus is the founder of CRISPR Therapeutics AG, founded in 2013.
Dr. Porteus was the founder of Graphite Bio, Inc., founded in 2017, and served as Director.
Dr. Porteus is also the founder of Kamau Therapeutics, Inc...
Dr. Porteus is a Professor at Stanford University.
Dr. Porteus is an Associate Professor at Stanford School of Medicine since 2010.
Dr. Porteus was an Assistant Professor at The University of Texas Southwestern Medical Center from 2003 to 2010.
Dr. Porteus completed undergraduate studies at Harvard University.
Dr. Porteus earned a doctorate from Stanford University.

Matthew Porteus active positions

CompaniesPositionStart
Corporate Officer/Principal 2010-09-30
Corporate Officer/Principal -

Former positions of Matthew Porteus

CompaniesPositionEnd
Corporate Officer/Principal 2010-07-31
LENZ THERAPEUTICS, INC. Founder -
CRISPR THERAPEUTICS AG Founder -
See the detail of Matthew Porteus's experience

Training of Matthew Porteus

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Consumer Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Matthew Porteus